Member Exclusive News

Repurposing a cancer drug to treat metabolic diseases

Scanning pharmaceutical databases using a new computational approach has led researchers to ibrutinib, originally developed to treat B-cell tumors, as a potential new treatment for metabolic diseases.

Go to the profile of Zoe Campbell
Nov 18, 2019

Please sign in or register for FREE

No comments yet.